ARTICLE | Clinical News
Somatuline Depot regulatory update
August 15, 2016 7:00 AM UTC
Ipsen said Teijin submitted a supplemental application in Japan for Somatuline lanreotide acetate to treat neuroendocrine tumors. The compound, an extended-release formulation of somatostatin analog ...